Domain Therapeutics
GPCR drug discovery therapies
- B2B
About Domain Therapeutics
Develops innovative immunotherapies targeting GPCRs to treat cancer, using a precise biomarker strategy for specific patient needs and individual cancer signatures.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11–50 employees
- Headquarters
- Illkirch-Graffenstaden, Grand Est, France
- Founded
- 2008
- Revenue
- €2.4MFY2024, filed accounts, INPI
- SIREN
- 439510512
- Website
- domaintherapeutics.com
Domain Therapeutics at a glance
Domain Therapeutics is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Illkirch-Graffenstaden, Grand Est, France.
Domain Therapeutics was founded in 2008.
Domain Therapeutics has 11–50 employees.
Domain Therapeutics's revenue is €2.4M (FY2024, filed accounts, INPI).
Domain Therapeutics's SIREN number is 439510512.
Frequently asked questions about Domain Therapeutics
What is Domain Therapeutics's revenue?
Domain Therapeutics's revenue is €2.4M (FY2024, filed accounts, INPI).
How many employees does Domain Therapeutics have?
Domain Therapeutics has 11–50 employees.
Where is Domain Therapeutics headquartered?
Domain Therapeutics is headquartered in Illkirch-Graffenstaden, Grand Est, France.
Selling to companies like Domain Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies